Prevention & lipidsCross-sectional study

Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China

CirculationPublished

  • Cross-sectional study
  • representative
  • community-based survey
  • 7 geographic regions of China

Authors' conclusion

Large and variable gaps in primary and secondary CVD prevention exist in China, particularly for women.

Study context

Population
Adults aged ≥45 years in China, 2014–201661.3% women
Participants
47,841 adults
Exposure
Women vs men
Outcome
Sex differences in primary and secondary CVD prevention (adjusted ORs)

Main finding

As reported in the abstract

Secondary prevention: medication use in established CVD (n 5454)
Women vs MenOdds ratio (95% CI)
BP-lowering medications
0.79(0.65–0.95)
lipid-lowering medications
0.69(0.56–0.84)
antiplatelets
0.53(0.45–0.62)
any CVD prevention medication
0.62(0.52–0.73)
Any blood pressure (BP)-lowering, lipid-lowering or antiplatelet therapy, primary prevention: women vs men
48.5% vs 39.3%
Any BP-lowering, lipid-lowering or antiplatelet therapy, secondary prevention: women vs men
48.6% vs 59.8%

Observational data: associations, not effects.

Further findings

OutcomeOR (95% CI)
Risk factor control in established CVD — Women vs Men · BP control1.31 (1.14–1.50)
Risk factor control in established CVD — Women vs Men · LDL-C control0.66 (0.57–0.76)
Risk factor control in established CVD — Women vs Men · less likely to smoke13.89 (11.24–17.15)
Risk factor control in established CVD — Women vs Men1.92 (1.61–2.29)
Primary prevention: high 10-year CVD risk ≥10% (n 9532) — Women vs Men · BP controlled0.46 (0.38–0.55)
Primary prevention: high 10-year CVD risk ≥10% (n 9532) — Women vs Men · LDL-C controlled0.60 (0.52–0.69)
Primary prevention: high 10-year CVD risk ≥10% (n 9532) — Women vs Men · bodyweight controlled0.55 (0.48–0.63)
Primary prevention: high 10-year CVD risk ≥10% (n 9532) — Women vs Men · use of BP-lowering medications1.21 (1.01–1.45)
  • Risk factor control in established cardiovascular disease (CVD): physical activity targets (reported as less likely to achieve)

Interactions by age, residence, education

Younger patients (<65 years) with established CVD less likely to take CVD preventive medications; no sex differences by area of residence or education level

Original publication

Sex Differences in Primary and Secondary Prevention of Cardiovascular Disease in China. Circulation. Published 17 February 2020. doi:10.1161/circulationaha.119.043731

Summarised from the published abstract; every number is checked against it